Page 51 - D. Cancer biology
P. 51

SPON2 Enhanced by Notch Signaling Marks Aggressive Tumor Growth in
  Gastric Cancer

  Hyeon-Gu Kang, Jun-Ho Jang and Seok-Jun Kim
  Department of  Integrative Biological Sciences, BK21 FOUR Educational Research Group for Age-associated Disorder Control Technology,
  College of Natural Sciences, Chosun University
                   BACKGROUND                                                  AIM

    SPON2 is involved in cancer progression and metastasis  We investigate the role of SPON2 and related signaling
   of many tumors; however, its role and underlying      pathway in gastric cancer progression and metastasis.
   mechanism in gastric cancer are still obscure. We
   identified SPON2 regulated through Notch signaling as
   potential target gene to inhibit gastric cancer progression.


                                                RESULTS


















                                                         Figure 2. SPON2 downregulation decreases cell
    Figure 1. SPON2 upregulates in patients with gastric  proliferation, migration, and invasion abilities in gastric
    cancer and is associated with poor prognosis         cancer cells.




















    Figure 3. Effect of SPON2 inhibition on tumor growth in  Figure 4. SPON2 expression is regulated by Notch
    xenografted mice.                                    signaling pathway.

    SPON2 expression levels were found to be upregulated in gastric cancer cell lines and patient tissues compared to normal
    gastric epithelial cells and normal controls. Furthermore, SPON2 silencing was observed to decrease cell proliferation and
    motility and reduce tumor growth in xenograft mice. Subsequently, we focused on regulatory mechanism of SPON2 in gastric
    cancer. We confirmed how Notch signaling pathway regulate SPON2 expression using Notch signaling-related transcription
    factor interaction and reporter gene assay. Our study demonstrated that Notch signaling-mediated SPON2 upregulation is
    associated with aggressive progression of gastric cancer.
            CONCLUSION                         REFERENCES                 ACKNOWLEDGEMENTS

                                          Kang et al., SPON2 Is Upregulated  This study was supported by the
                                          through Notch Signaling Pathway and  Chosun University in 2020. Also helped
                                          Promotes  Tumor  Progression  in  by lab members.
                                          Gastric Cancer. Cancers 2020, 12(6),
                                          1439.                           Contact information

                                                                          kang84562@nate.com
                                                                          010-5539-3058
   46   47   48   49   50   51   52   53   54   55   56